In human cancer, TIPE2 is weakly expressed in hepatocellular carcinoma (9), small cell lung cancer (24), gastric cancer (25), breast cancer (26), esophageal cancer (27) and oral tongue squamous cell carcinoma (19), which demonstrated that TIPE2 was involved in cancer progression. Here, TIPE2 is linked to esophageal cancer.